Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant non-small cell lung cancer harbouring MET/AXL dysregulation

Keunchil ParkGee-Chen ChangGiuseppe CuriglianoWan-Teck LimRoss A. SooMiguel A. Molina-VilaValérie CattanHélène DarvilleEric GandossiVeronika SmutnaIsabelle SudeySantiago Viteri2026-01-302026-01-302021-0510.1016/j.lungcan.2021.03.012https://scholars.csmu.edu.tw/handle/123456789/4163[SDGs]SDG3Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant non-small cell lung cancer harbouring MET/AXL dysregulationjournal-article